Alpha-tocopherol succinate-and AMD3100-mobilized progenitors mitigate radiation combined injury in mice

Journal of Radiation Research

Volumn 55, Issue 1, 2014, Pages 41-53

  Singh, Vijay K ^a,b   Wise, Stephen Y ^a   Fatanmi, Oluseyi O ^a   Beattie, Lindsay A ^a   Ducey, Elizabeth J ^a   Seed, Thomas M ^c  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c Tech Micro Services   (United States)

Author keywords

cytokines; gamma radiation; hematopoietic progenitor cells; mice; transfusion

Indexed keywords

IRRADIATION; MAMMALS;

COBALT-60; CYTOKINES; EXPOSED TO; HEMATOPOIETIC PROGENITOR CELLS; HIGH DOSE; LUMINEX; MOUSE; PERIPHERAL BLOOD MONONUCLEAR CELLS; RADIATION EXPOSURE; TRANSFUSION;

GAMMA RAYS;

ALPHA TOCOPHEROL; HETEROCYCLIC COMPOUND; PLERIXAFOR; RADIOPROTECTIVE AGENT;

ANIMAL; MALE; MOUSE; MULTIMODALITY CANCER THERAPY; MULTIPLE TRAUMA; PATHOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROCEDURES; RADIATION DOSE; RADIATION INJURIES; RADIATION RESPONSE; SURVIVAL RATE; TREATMENT OUTCOME; WOUNDS, PENETRATING;

ALPHA-TOCOPHEROL; ANIMALS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HETEROCYCLIC COMPOUNDS; MALE; MICE; MULTIPLE TRAUMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RADIATION DOSAGE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; SURVIVAL RATE; TREATMENT OUTCOME; WOUNDS, PENETRATING;

EID: 84892741250     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrt088     Document Type: Article

References (61)

1. Carter AB, May MM, Perry WJ. The day after: action following a nuclear blast in a U.S. city. Washington Quarterly 2007;30:19-32.
2. Pellmar TC, Rockwell S. Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res 2005;163:115-23.
3. Grace MB, Singh VK, Rhee JG et al. 5-AED enhances survival of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function, reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and apoptosis. J Radiat Res 2012;53:840-53.
4. Benjamin GC, McGeary M, McCutchen SR. Assessing medical preparedness to respond to a terrorist nuclear event. Workshop Report. Washington, DC: The National Academies Press, 2009.
5. Kishi HS. Effects of the "special bomb": recollections of a neurosurgeon in Hiroshima, August 8-15, 1945. Neurosurgery 2000;47:441-5; discussion 45-6.
6. Iijima S. Pathology of atomic bomb casualties. Acta Pathol Jpn 1982;32 Suppl 2:237-70.
7. Barabanova AV. Significance of beta-radiation skin burns in Chernobyl patients for the theory and practice of radiopathol-ogy. Vojnosanit Pregl 2006;63:477-80.
8. Ledney GD, Elliott TB. Combined injury: factors with potential to impact radiation dose assessments. Health Phys 2010;98:145-52.
9. Kiang JG, Jiao W, Cary LH et al. Wound trauma increases radiation-induced mortality by activation of iNOS pathway and elevation of cytokine concentrations and bacterial infection. Radiat Res 2010;173:319-32.
10. Valeriote FA, Baker DG. The combined effects of thermal trauma and X-irradiation on early mortality. Radiat Res 1964;22:693-702.
11. Alpen EL, Sheline GE. The combined effects of thermal burns and whole body X irradiation on survival time and mortality. Ann Surg 1954;140:113-8.
12. Korlof B. Infection of burns. I. A bacteriological and clinical study of 99 cases. II. Animal experiments; burns and total body x-irradiation. Acta Chir Scand Suppl 1956;209:1-144.
13. Brooks JW, Evans EI, Ham WT, Jr et al. The influence of external body radiation on mortality from thermal burns. Ann Surg 1952;136:533-45.
14. Baxter H, Drummond JA, Stephens-Newsham LG et al. Studies on acute total body irradiation in animals. I. Effect of streptomycin following exposure to a thermal burn and irradiation. Plast Reconstr Surg (1946) 1953;12:439-45.
15. Ledney GD, Elliott TB, Moore MM. Modulation of mortality by tissue trauma and sepsis in mice after radiation injury. In: Mossman KL, Mill WA (eds). The Biological Basis of Radiation Protection Practice. Baltimore: Williams and Wilkins, 1992, 202-17.
16. DiCarlo AL, Maher C, Hick JL et al. Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation. Disaster Med Public Health Prep 2011;5 Suppl 1:S32-44.
17. Koenig KL, Goans RE, Hatchett RJ et al. Medical treatment of radiological casualties: current concepts. Ann Emerg Med 2005;45:643-52.
18. Lausevic Z, Lausevic M, Trbojevic-Stankovic J et al. Predicting multiple organ failure in patients with severe trauma. Can J Surg 2008;51:97-102.
19. Zou Z, Sun H, Su Y et al. Progress in research on radiation combined injury in China. Radiat Res 2008;169:722-9.
20. DiCarlo AL, Ramakrishnan N, Hatchett RJ. Radiation combined injury: overview of NIAID research. Health Phys 2010;98:863-7.
21. Fliedner TM, Dorr HD, Meineke V. Multi-organ involvement as a pathogenetic principle of the radiation syndromes: a study involving 110 case histories documented in SEARCH and classified as the bases of haematopoietic indicators of effect. Br J Radiol Suppl 2005;27:1-8.
22. Singh VK, Singh PK, Wise SY et al. Radioprotective properties of tocopherol succinate against ionizing radiation in mice. J Radiat Res 2013;54:210-20.
23. Singh PK, Wise SY, Ducey EJ et al. Alpha-tocopherol succin-ate protects mice against radiation-induced gastrointestinal injury. Radiat Res 2012;177:133-45.
24. Singh VK, Brown DS, Kao TC. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor. Int J Radiat Biol 2010;86:12-21.
25. Singh PK, Wise SY, Ducey EJ et al. Radioprotective efficacy of tocopherol succinate is mediated through granulocyte-colony stimulating factor. Cytokine 2011;56:411-21.
26. Singh VK, Brown DS, Kao TC et al. Preclinical development of a bridging therapy for radiation casualties. Exp Hematol 2010;38:61-70.
27. Singh VK, Wise SY, Singh PK et al. Alpha-tocopherol succinate-and AMD3100-mobilized progenitors mitigate radiation-induced gastrointestinal injury in mice. Exp Hematol 2012;40:407-17.
28. Singh VK, Wise SY, Singh PK et al. Alpha-tocopherol succinate-mobilized progenitors improve intestinal integrity after whole body irradiation. Int J Radiat Biol 2013;89:334-45.
29. Uy GL, Rettig MP, Cashen AF. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells. Expert Opin Biol Ther 2008;8:1797-804.
30. Gupta SK, Pillarisetti K, Thomas RA et al. Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists. Immunol Lett 2001;78:29-34.
31. Jin F, Zhai Q, Qiu L et al. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization. Bone Marrow Transplant 2008;42:581-8.
32. Hatse S, Princen K, Bridger G et al. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 2002;527:255-62.
33. Damon LE. Mobilization of hematopoietic stem cells into the peripheral blood. Expert Rev Hematol 2009;2:717-33.
34. Singh VK, Ducey EJ, Fatanmi OO et al. CBLB613: a TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini, as a novel radiation countermeasure. Radiat Res 2012;177:628-42
35. National Research Council of the National Academy of Sciences. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press, 2011.
36. Broxmeyer HE, Orschell CM, Clapp DW et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005;201:1307-18.
37. Flomenberg N, Devine SM, Dipersio JF et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005;106:1867-74.
38. Pulliam AC, Hobson MJ, Ciccone SL et al. AMD3100 syner-gizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice. Exp Hematol 2008;36:1084-90.
39. Broxmeyer HE, Orschell CM, Clapp DW et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005;201:1307-18.
40. Nagy VV. Accuracy considerations in EPR dosimetry. Appl Radiat Isot 2000;52:1039-50.
41. ISO-ASTM. Standard practice for use of an alanine dosimetry. ISO/ASTM International Standard 2004:5167.
42. Shakhov AN, Singh VK, Bone F et al. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopep-tide agonists of Toll-like receptor 2 (TLR2). PLOS ONE 2012;7:e33044.
43. Singh VK, Christensen J, Fatanmi OO et al. Myeloid progenitors: a radiation countermeasure that is effective when initiated days after irradiation. Radiat Res 2012;177:781-91.
44. Krivokrysenko VI, Shakhov AN, Singh VK et al. Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasure. J Pharmacol Exp Ther 2012;343:497-508.
45. Blumenthal RD, Reising A, Leon E et al. Modulation of marrow proliferation and chemosensitivity by tumor-produced cytokines from syngeneic pancreatic tumor lines. Clin Cancer Res 2002;8:1301-9.
46. Iwakawa M, Noda S, Ohta T et al. Different radiation susceptibility among five strains of mice detected by a skin reaction. J Radiat Res 2003;44:7-13.
47. Lindsay KJ, Coates PJ, Lorimore SA et al. The genetic basis of tissue responses to ionizing radiation. Br J Radiol 2007;80 Spec No 1:S2-6.
48. Singh VK, Ducey EJ, Brown DS et al. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int J Radiat Biol 2012;88: 296-310.
49. Singh VK, Fatanmi OO, Singh PK et al. Role of radiation-induced granulocyte colony-stimulating factor in recovery from whole body gamma-irradiation. Cytokine 2012;58:406-14.
50. Kulkarni S, Singh PK, Ghosh SP et al. Granulocyte colony-stimulating factor antibody abrogates radioprotective efficacy of gamma-tocotrienol, a promising radiation counter-measure. Cytokine 2013;62:278-85.
51. Singh VK, Brown DS, Kao TC. Tocopherol succinate: a promising radiation countermeasure. Int Immunopharmacol 2009;9:1423-30.
52. Kim JS, Ryoo SB, Heo K et al. Attenuating effects of granulocyte-colony stimulating factor (G-CSF) in radiation induced intestinal injury in mice. Food Chem Toxicol 2012;50:3174-80.
53. Singh VK, Singh PK, Wise SY et al. Mobilized progenitor cells as a bridging therapy for radiation casualties: a brief review of tocopherol succinate-based approaches. Int Immunopharmacol 2011;11:842-47.
54. Lai L, Zhang M, Goldschneider I. Recombinant IL-7/HGFbeta efficiently induces transplantable murine hematopoietic stem cells. J Clin Invest 2012;122:3552-62.
55. Mason KA, Withers HR, McBride WH et al. Comparison of the gastrointestinal syndrome after total-body or total-abdominal irradiation. Radiat Res 1989;117:480-8.
56. Farese AM, MacVittie TJ, Roskos L et al. Hematopoietic recovery following autologous bone marrow transplantation in a nonhuman primate: effect of variation in treatment schedule with PEG-rHuMGDF. Stem Cells 2003;21:79-89.
57. Johnston E, Crawford J, Blackwell S et al. Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy. J Clin Oncol 2000;18:2522-8.
58. Schooltink H, Rose-John S. Cytokines as therapeutic drugs. J Interferon Cytokine Res 2002;22:505-16.
59. Dinarello CA. A clinical perspective of IL-1 beta as the gatekeeper of inflammation. Eur J Immunol 2011;41:1203-17.
60. Pappu R, Ramirez-Carrozzi V, Sambandam A. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 2011;134:8-16.
61. Ledney GD, Elliott TB. Combined injury: factors with potential to impact radiation dose assessments. Health Phys 2010;98:145-52.